Dror Ortho-Design, Inc. reported a net loss of $1,784,697 for the nine months ended September 30, 2026, compared to $1,988,989 in the prior year period. The company remains in the research and development stage with no revenue, and management has expressed substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $23.8 million and negative working capital.
Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement to sell $245,000 in aggregate principal amount of 0% interest debentures due December 31, 2026. The private placement also includes the future issuance of warrants to purchase common stock, with the specific number of warrants contingent upon the consummation of a future public offering.
Stockholders of Dror Ortho-Design, Inc. approved an amendment to the company's Certificate of Incorporation to effect a reverse stock split of its common stock. The board of directors has the discretion to determine the final ratio within a range of 1-for-2 to 1-for-2,000 and the timing of the split within one year of the approval.